Art. 101(1) TFEU: A Bitter Pill For Hoffmann-La Roche

Research output: Other contributionAcademic


A blogpost on the recent Judgment by the Court of Justice in Case C-179/16, F. Hoffmann-La Roche Ltd e.a. v. Autorità Garante della Concorrenza e del Mercato, 23 January 2018, discussing the Court's application of the competition rules on the relevant market definition and anti-competitive restrictions by object to two medicinal products.
Original languageEnglish
Media of outputEuropean Law Blog
Number of pages5
Publication statusPublished - 26-Feb-2018


  • Article 101 TFEU
  • Healthcare
  • European Law
  • Competition law

Cite this